Document is current
Any future updates will be listed below
-
Authors
Caulfield, Jasmine I. https://orcid.org/0000-0002-0175-968X
Kluger, Harriet M. https://orcid.org/0000-0002-4932-9873
-
Funding
Funding for this research was provided by:
National Cancer Institute (T32CA193200)
- License Information
-
More Information
Article History
Accepted: 17 November 2021
First Online: 25 February 2022
Declarations
:
: Jasmine I. Caulfield declares that she has no conflict of interest. Harriet M. Kluger has received institutional research grants from Merck, Bristol-Myers Squibb, and Apexigen; has received compensation for service as a consultant from Merck, Bristol-Myers Squibb, Nektar Therapeutics, Iovance Biotherapeutics, Immunocore, Array BioPharma, Instil Bio, ElevateBio, Clinigen, Shionogi, ChemoCentryx, Calithera Biosciences, and Signatero; and has received reimbursement for travel/accommodations from Apexigen. Dr. Caulfield received salary support from NCI T32CA193200 (PIs: Glazer/Stern).
